Drug Shortage Report for MYLAN-BUPROPION XL
| Report ID | 133595 |
| Drug Identification Number | 02382083 |
| Brand name | MYLAN-BUPROPION XL |
| Common or Proper name | BUPROPION |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 90BT, 100BT |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-04-07 |
| Actual start date | 2021-03-29 |
| Estimated end date | |
| Actual end date | 2022-08-18 |
| Shortage status | Resolved |
| Updated date | 2022-08-25 |
| Company comments | Last lot 3107588, Expiry Dec-31-2021. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-08-25 | French | Compare |
| v5 | 2022-08-25 | English | Compare |
| v4 | 2021-04-07 | French | Compare |
| v3 | 2021-04-07 | English | Compare |
| v2 | 2021-02-09 | French | Compare |
| v1 | 2021-02-09 | English | Compare |
Showing 1 to 6 of 6